Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | GBA1 | P04062 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23352576 | 1.00 | ALDH1A1 (0.38) | ALDH1A1SLC2A1MAPK1RAB9AALOX15 | |
| SCHEMBL8425536 | 0.73 | ALDH1A1 (0.42) | ALDH1A1SLC2A1MAPK1RAB9AALOX15 | |
| SCHEMBL13934134 | 0.70 | ALDH1A1 (0.47) | ALDH1A1SLC2A1MAPK1RAB9AALOX15 | |
| SCHEMBL10632064 | 0.69 | SLC2A1 (0.44) | ALDH1A1SLC2A1RAB9ATSHRNPC1 | |
| SCHEMBL27571573 | 0.69 | SLC2A1 (0.44) | ALDH1A1SLC2A1RAB9ATSHRNPC1 | |
| SCHEMBL575744 | 0.69 | — | — | |
| SCHEMBL8700406 | 0.69 | SLC2A1 (0.44) | ALDH1A1SLC2A1RAB9ATSHRNPC1 | |
| SCHEMBL1200818 | 0.67 | KMT2A (0.46) | ALDH1A1MAPK1RAB9AALOX15TSHR | |
| SCHEMBL24564744 | 0.67 | KMT2A (0.46) | ALDH1A1MAPK1RAB9AALOX15TSHR | |
| SCHEMBL979441 | 0.67 | ALDH1A1 (0.45) | ALDH1A1SLC2A1MAPK1RAB9AALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200190165-A1 | COMPOUND HAVING AFFINITY SUBSTANCE TO SOLUBLE PROTEIN, CLEAVABLE PORTION AND REACTIVE GROUP, OR SALT THEREOF | AJINOMOTO CO., INC. (JP) | 2020-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200190165-A1 | COMPOUND HAVING AFFINITY SUBSTANCE TO SOLUBLE PROTEIN, CLEAVABLE PORTION AND REACTIVE GROUP, OR SALT THEREOF | SPPL2B, CSTB, SPPL2A | ALDH1A1 1832/4885SLC2A1 3906/4885MAPK1 998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.